BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30185656)

  • 1. Induction of antiinflammatory purinergic signaling in activated human iNKT cells.
    Yu JC; Lin G; Field JJ; Linden J
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymes of the purinergic signaling system exhibit diverse effects on the degeneration of valvular interstitial cells in a 3-D microenvironment.
    Weber A; Barth M; Selig JI; Raschke S; Dakaras K; Hof A; Hesse J; Schrader J; Lichtenberg A; Akhyari P
    FASEB J; 2018 Aug; 32(8):4356-4369. PubMed ID: 29558203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors.
    Lin G; Field JJ; Yu JC; Ken R; Neuberg D; Nathan DG; Linden J
    PLoS One; 2013; 8(10):e74664. PubMed ID: 24124453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
    Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
    Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.
    Field JJ; Lin G; Okam MM; Majerus E; Keefer J; Onyekwere O; Ross A; Campigotto F; Neuberg D; Linden J; Nathan DG
    Blood; 2013 Apr; 121(17):3329-34. PubMed ID: 23377438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The A2aR adenosine receptor controls cytokine production in iNKT cells.
    Nowak M; Lynch L; Yue S; Ohta A; Sitkovsky M; Balk SP; Exley MA
    Eur J Immunol; 2010 Mar; 40(3):682-7. PubMed ID: 20039304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
    Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
    Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
    Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
    Front Immunol; 2018; 9():1266. PubMed ID: 29928278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Invariant NKT Cells Induce IL-1β Secretion by Peripheral Blood Monocytes via a P2X7-Independent Pathway.
    Felley LE; Sharma A; Theisen E; Romero-Masters JC; Sauer JD; Gumperz JE
    J Immunol; 2016 Sep; 197(6):2455-64. PubMed ID: 27534556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease.
    Wallace KL; Linden J
    Blood; 2010 Dec; 116(23):5010-20. PubMed ID: 20798237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion Injury.
    Sharma AK; LaPar DJ; Stone ML; Zhao Y; Mehta CK; Kron IL; Laubach VE
    Am J Respir Crit Care Med; 2016 May; 193(9):988-99. PubMed ID: 26757359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies.
    Rabin J; Zhao Y; Mostafa E; Al-Suqi M; Fleischmann E; Conaway MR; Mann BJ; Chhabra P; Brayman KL; Krupnick A; Linden J; Lau CL
    PLoS One; 2023; 18(8):e0288920. PubMed ID: 37566593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
    Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
    PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury.
    Nowak-Machen M; Schmelzle M; Hanidziar D; Junger W; Exley M; Otterbein L; Wu Y; Csizmadia E; Doherty G; Sitkovsky M; Robson SC
    Am J Respir Cell Mol Biol; 2013 May; 48(5):601-9. PubMed ID: 23349052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankylosing spondylitis monocyte-derived macrophages express increased level of A
    Akhtari M; Zargar SJ; Mahmoudi M; Vojdanian M; Rezaeimanesh A; Jamshidi A
    Clin Rheumatol; 2018 Jun; 37(6):1589-1595. PubMed ID: 29524036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human iNKT Cells Promote Protective Inflammation by Inducing Oscillating Purinergic Signaling in Monocyte-Derived DCs.
    Xu X; Pocock GM; Sharma A; Peery SL; Fites JS; Felley L; Zarnowski R; Stewart D; Berthier E; Klein BS; Sherer NM; Gumperz JE
    Cell Rep; 2016 Sep; 16(12):3273-3285. PubMed ID: 27653689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting iNKT cells for the treatment of sickle cell disease.
    Field JJ; Nathan DG; Linden J
    Clin Immunol; 2011 Aug; 140(2):177-83. PubMed ID: 21429807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
    Yoshida K; Ito M; Matsuoka I
    Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of circulating invariant natural killer cell subsets are skewed toward Th2-like phenotype in children with sickle cell disease.
    Boulassel MR; Al-Zubaidi A; Al-Zadjali S; Al-Qarni Z; Al-Naamany N; Al-Yarabi A; Elshinawy M; Wali Y
    Clin Immunol; 2020 Jan; 210():108308. PubMed ID: 31726101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
    Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
    Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.